Lucica Glycated Albumin-L— 510(k) K170147

Substantially Equivalent

Asahi Kasei Pharma Corporation

FDA 510(k) clearance K170147 for Lucica Glycated Albumin-L, Substantially Equivalent on 2017-10-12. Applicant: Asahi Kasei Pharma Corporation.

Clearance details

Applicant
Asahi Kasei Pharma Corporation
Product code
Code LCP
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Tokyo, JP
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.